Patients, not physicians, should decide if DPYD screening is right for them before FU/Xeloda chemotherapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/OP.24.00443 | DOI Listing |
Publication Analysis
Top Keywords
patients choice
4
choice test
4
test dpd
4
dpd deficiency
4
deficiency fluoropyrimidine
4
fluoropyrimidine chemotherapy
4
chemotherapy patients
4
patients physicians
4
physicians decide
4
decide dpyd
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!